Lipoic acid in multiple sclerosis: a pilot study (Q46407394)

21 December 2017

title

Lipoic acid in multiple sclerosis: a pilot study (English)

1 reference

21 December 2017

0 references

V Yadav

1

1 reference

21 December 2017

G Marracci

2

1 reference

21 December 2017

J Lovera

3

1 reference

21 December 2017

W Woodward

4

1 reference

21 December 2017

K Bogardus

5

1 reference

21 December 2017

W Marquardt

6

1 reference

21 December 2017

L Shinto

7

1 reference

21 December 2017

C Morris

8

1 reference

21 December 2017

D Bourdette

9

1 reference

21 December 2017

publication date

1 April 2005

1 reference

21 December 2017

Multiple Sclerosis Journal

published in

1 reference

21 December 2017

volume

11

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

159-165

1 reference

21 December 2017

Immunopathogenesis of multiple sclerosis: the role of T cells

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Ligand-Induced TCR Down-Regulation Is Not Dependent on Constitutive TCR Cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Cell migration in the immune system: the evolving inter-related roles of adhesion molecules and proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Synovial fluid levels of E-selectin and intercellular adhesion molecule-1: relationship to joint inflammation in children with chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Acute myocardial infarction and increased soluble intercellular adhesion molecule-1: a marker of vascular inflammation and a risk of early restenosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Determination of oxidized and reduced lipoic acid using high-performance liquid chromatography and coulometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Alpha-lipoic acid modulates NF-kappaB activity in human monocytic cells by direct interaction with DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1143OA

10.1191/1352458505MS1143OA

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

15794388

1 reference

21 December 2017